Macrorecombination in isolated cell pairs via natural genetic transformation
通过自然遗传转化在分离的细胞对中进行宏重组
基本信息
- 批准号:10609526
- 负责人:
- 金额:$ 58.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-21 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAntibiotic ResistanceAntibiotic TherapyAntibioticsBacteriaBase PairingCell CommunicationCell SeparationCellsCessation of lifeClinicalComplexCytolysisDNADangerousnessDevelopmentDevicesDiameterDiseaseEffectivenessEventFailureGene ExchangesGene TransferGenerationsGenesGeneticGenetic RecombinationGenetic TransformationGenomeGenomic SegmentGenomicsGram-Positive BacteriaHorizontal Gene TransferImmuneIn VitroIndividualInfectionIntelligenceInterventionLaboratoriesLyticMapsMeasuresMediatingMedicalMeningitisMicrobial BiofilmsMicrofluidic MicrochipsMicrofluidicsModelingMolecularNamesNucleotidesParticipantPathogenicityPatientsPatternPeptidesPneumoniaPopulationProcessPropertyReportingResolutionSepsisSerotypingStreptococcusStreptococcus pneumoniaeSystemTimeVaccinationVaccinesVirulence FactorsVisualVisualizationWorkaqueousbactericidecell transformationcombatflexibilitygenome sequencinggenome-widehuman pathogenmetermodel organismnovel therapeuticspathogenpathogenic bacteriaprophylacticresistance generesistant strainsuccesstooluptakevaccine formulationwhole genome
项目摘要
Abstract /Summary:
Streptococcus pneumoniae (pneumococcus) is a major global bacterial human pathogen, causing
~1 million deaths annually worldwide, due to pneumonia, sepsis, and meningitis. Two strategies
are used to combat such infections. Antibiotics can often cure such infections, and vaccines are
used to reduce the circulating populations of the most dangerous serotypes. However, both
strategies are failing at an increasing rate. Antibiotic resistant strains are continually arising and
spreading globally; vaccination effectiveness is also under challenge, as serotypes not targeted
by current vaccine formulations are continually arising and rapidly replacing the targeted ones.
The cause of these failures is transfer of multiple foreign genes into the bacteria, but the
mechanisms that create the new infectious and resistant strain types are unclear. Transfer events
are of two types, named as micro- and macro-recombination events. The micro events, involving
dozens to several thousands of base pairs, are consistent with the known properties of gene
transfer by transformation in pneumococcus. However, more significant events involve transfer of
multiple blocks of tens of thousands of nucleotides, sometimes all from a single donor strain.
These macro-recombination events were difficult to reconcile completely with any known
mechanism of gene transfer - whether conjugation, transduction, or transformation. This project
would use microfluidics to create numerous small chambers (droplets) within which attacker-
target interactions can be studied and characterized for the first time at both the cellular and
molecular levels, both by identifying the participant cells and by tracing all gene exchange events
at full genome scale and 200-bp resolution.
Medical Relevance. Most pathogenic streptococci share the mechanism of gene transfer by
natural genetic transformation. Genetic transformation is an important path for genetic flexibility
in pneumococcus, where it is documented as key to vaccine escape and creation and spread of
new drug-resistance genes. Because Streptococcus pneumoniae is a model organism for the
study of DNA uptake, this work on the mechanism that transfers unexpectedly large blocks of
genes between strains or species will have broad impacts on understanding and targeting the
many similar peptide regulated gene exchange systems among Gram positive bacteria that are
often associated with the ability of these bacteria to cause disease.
摘要/总结:
肺炎链球菌(肺炎球菌)是一种主要的全球细菌性人类病原体,可引起
全球每年约有 100 万人死于肺炎、败血症和脑膜炎。两种策略
用于对抗此类感染。抗生素通常可以治愈此类感染,而疫苗则是
用于减少最危险血清型的循环种群。然而,两者
战略的失败率越来越高。抗生素耐药菌株不断出现
传播到全球;由于血清型没有针对性,疫苗接种的有效性也受到挑战
当前的疫苗配方不断出现并迅速取代目标疫苗配方。
这些失败的原因是多个外源基因转移到细菌中,但是
产生新的感染性和耐药性菌株类型的机制尚不清楚。转会事件
有两种类型,称为微观重组事件和宏观重组事件。微观事件包括
几十到几千个碱基对,与基因的已知特性一致
肺炎球菌中通过转化进行转移。然而,更重要的事件涉及转让
数万个核苷酸的多个块,有时全部来自单个供体菌株。
这些宏观重组事件很难与任何已知的完全一致
基因转移的机制——无论是接合、转导还是转化。这个项目
将使用微流体技术创建许多小室(液滴),攻击者在其中
首次可以在细胞和细胞层面上研究和表征靶标相互作用
分子水平,通过识别参与细胞和追踪所有基因交换事件
全基因组规模和 200 bp 分辨率。
医学相关性。大多数致病性链球菌都具有相同的基因转移机制:
自然遗传转化。遗传转化是遗传灵活性的重要途径
在肺炎球菌中,它被记录为疫苗逃逸、产生和传播的关键
新的耐药基因。因为肺炎链球菌是一种模式生物
DNA 摄取的研究,这项工作研究了意外转移大块 DNA 的机制
菌株或物种之间的基因将对理解和靶向
革兰氏阳性菌之间有许多类似的肽调节基因交换系统
通常与这些细菌引起疾病的能力有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Eddington其他文献
David Eddington的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Eddington', 18)}}的其他基金
Macrorecombination in isolated cell pairs via natural genetic transformation
通过自然遗传转化在分离的细胞对中进行宏重组
- 批准号:
10291368 - 财政年份:2021
- 资助金额:
$ 58.32万 - 项目类别:
Macrorecombination in isolated cell pairs via natural genetic transformation
通过自然遗传转化在分离的细胞对中进行宏重组
- 批准号:
10408835 - 财政年份:2021
- 资助金额:
$ 58.32万 - 项目类别:
Confined Genetic Transformation and Exchange of Antibiotic Resistance Genes in Femtoliter Microdroplets
飞升微滴中抗生素抗性基因的有限遗传转化和交换
- 批准号:
9369924 - 财政年份:2017
- 资助金额:
$ 58.32万 - 项目类别:
microBSD:Spatiotemporal control of neurochemical tone in the brain slice using mi
microBSD:使用 mi 对脑切片中的神经化学音调进行时空控制
- 批准号:
7835750 - 财政年份:2009
- 资助金额:
$ 58.32万 - 项目类别:
Probing Combinatorial Hepatocellular Microenvironments
探索组合肝细胞微环境
- 批准号:
6994097 - 财政年份:2005
- 资助金额:
$ 58.32万 - 项目类别:
Probing Combinatorial Hepatocellular Microenvironments
探索组合肝细胞微环境
- 批准号:
7136290 - 财政年份:2005
- 资助金额:
$ 58.32万 - 项目类别:
Cholesterol Regulation of Endothelial K+ Channels
内皮 K 通道的胆固醇调节
- 批准号:
8721685 - 财政年份:2004
- 资助金额:
$ 58.32万 - 项目类别:
Cholesterol Regulation of Endothelial K+ Channels
内皮 K 通道的胆固醇调节
- 批准号:
9263758 - 财政年份:2004
- 资助金额:
$ 58.32万 - 项目类别:
Cholesterol Regulation of Endothelial K+ Channels
内皮 K 通道的胆固醇调节
- 批准号:
9060393 - 财政年份:2004
- 资助金额:
$ 58.32万 - 项目类别:
相似国自然基金
多环芳烃影响大肠杆菌抗生素耐药性进化的分子机制
- 批准号:32301424
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向铜绿假单胞菌FpvA蛋白的铁载体偶联抗生素克服细菌耐药性及作用机制研究
- 批准号:82304313
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
乙醇脱氢酶AdhB介导肺炎链球菌抗生素耐药性的机制研究
- 批准号:32300154
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
鸭肠道菌群抗生素耐药性分布及替抗噬菌体内溶素鉴定研究
- 批准号:32360830
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
消毒剂-抗生素循环压力下鲍曼不动杆菌耐药性演变及其作用机制
- 批准号:82273586
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Investigating phage therapy for the treatment of urinary tract infections
研究噬菌体疗法治疗尿路感染
- 批准号:
10677257 - 财政年份:2023
- 资助金额:
$ 58.32万 - 项目类别:
“Protection from MRSA lethality by inhibiting LXRα phosphorylation”
– 通过抑制 LXRα 磷酸化来防止 MRSA 致死 –
- 批准号:
10681027 - 财政年份:2023
- 资助金额:
$ 58.32万 - 项目类别:
Investigating phage therapy for the treatment of urinary tract infections
研究噬菌体疗法治疗尿路感染
- 批准号:
10677257 - 财政年份:2023
- 资助金额:
$ 58.32万 - 项目类别:
An Integrated Catheter Dressing for Early Detection of Catheter-related Bloodstream Infections
用于早期检测导管相关血流感染的集成导管敷料
- 批准号:
10647072 - 财政年份:2023
- 资助金额:
$ 58.32万 - 项目类别:
The role of master regulator NtrC in amyloid fibril dependent pathogenic traits of Pseudomonas aeruginosa
主调节因子 NtrC 在铜绿假单胞菌淀粉样原纤维依赖性致病性状中的作用
- 批准号:
10652868 - 财政年份:2023
- 资助金额:
$ 58.32万 - 项目类别: